Cannulight Technology Limited is a New Zealand based medical device company (with USA, UK, and Australian subsidiaries). The Cannulight device improves first-stick IV access success rates, especially in emergency, non hospital environments. Cannulight is backed by US military funding, and FDA clearance of the device is expected in late 2025.